No longer just for defendants

By Maulin Shah

Invalidity studies have emerged as a valuable resource for patent monetisation, management and investment, and are increasingly being used by rights holders and even potential buyers

Invalidity analysis is becoming an increasingly important factor in IP strategy and management, not only for defendants in patent infringement suits, but also for patent owners fine-tuning their strategy or monetising parts of their portfolio, and for buyers wishing to identify reliable and appropriately undervalued assets.

Want to read more?

Register to access two of our subscriber-only articles per month

Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts

Already registered? Log in

What our customers are saying

IAM is a high quality magazine with in-depth articles about intellectual asset management not found in any other publication. It adds value to our profession!

Katharine Ku
Director of the office of technology licensing
Stanford University


Subscribe to receive access to the full range of premium business intelligence, insights and analysis, as well as our IP directories, guides and daily news.

Why subscribe?


Register for more free content

  • Read more IAM blogs and articles
  • Receive the editor's weekly review by email
Register now  
Issue 90